Allen James Meglin serves as Executive at Organicell Regenerative Medicine, Inc., where they oversee executive responsibilities. Since joining the company, Allen James Meglin has executed 9 insider transactions totaling $344.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 21, 2020 involved purchasing 1,000,000 shares valued at $0.
Allen James Meglin currently holds 14,589,180 shares of Organicell Regenerative Medicine, Inc. (BPSR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allen James Meglin has been a net buyer of BPSR stock. They have purchased $344.3K and sold $0 worth of shares.
Allen James Meglin's most recent insider trade was on Dec 21, 2020, when they purchased 1,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.08 |
| Discretionary |
| Aug 19, 2020 | BPSR | $42.3K | Purchase | 422,514 | $0.10 | Discretionary |
| Jul 16, 2020 | BPSR | $35.0K | Purchase | 1,166,666 | $0.03 | Discretionary |
| May 22, 2020 | BPSR | $50.0K | Purchase | 2,500,000 | $0.02 | Discretionary |
| May 14, 2020 | BPSR | $50.0K | Purchase | 2,500,000 | $0.02 | Discretionary |
| Apr 30, 2020 | BPSR | $20.0K | Purchase | 1,000,000 | $0.02 | Discretionary |
| Apr 21, 2020 | BPSR | $27.0K | Purchase | 1,350,000 | $0.02 | Discretionary |
| Apr 8, 2020 | BPSR | $70.0K | Purchase | 3,500,000 | $0.02 | Discretionary |